Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip van den Bosch

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Brief report: erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitisSofia Ramiro, Astrid van Tubergen, Désirée van der Heijde, et al.
RMD Open|October 1, 2019
Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension studyXenofon Baraliakos, Juergen Braun, Atul Deodhar, et al.
Rheumatology (Oxford, England)|September 20, 2015
Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International StudyCasper Webers, Ivette Essers, Sofia Ramiro, et al.
Rheumatology and Therapy|October 18, 2021
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2Vibeke Strand, Filip Van den Bosch, Roberto Ranza, et al.
The Journal of Rheumatology|May 19, 2009
Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcomeAnnelies Boonen, Bert vander Cruyssen, Kurt de Vlam, et al.
Annals of the Rheumatic Diseases|January 31, 2007
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practiceBert Vander Cruyssen, Clio Ribbens, Annelies Boonen, et al.
Rheumatology (Oxford, England)|December 23, 2025
Work participation and work disability in Belgian patients with systemic sclerosisIne Desimpele, Ann-Sophie De Craemer, Saskia Decuman, et al.
RMD Open|April 4, 2025
Long-term evolution of postpartum sacroiliac bone marrow oedema: a 5-year longitudinal follow-up studyGaëlle Varkas, Liesbet De Meester, Manouk de Hooge, et al.
The Journal of Rheumatology|October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activityBert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
RMD Open|May 3, 2023
Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohortsManouk de Hooge, Alla Ishchenko, Ann-Sophie De Craemer, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Brief report: erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitisSofia Ramiro, Astrid van Tubergen, Désirée van der Heijde, et al.
RMD Open|October 1, 2019
Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension studyXenofon Baraliakos, Juergen Braun, Atul Deodhar, et al.
Rheumatology (Oxford, England)|September 20, 2015
Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International StudyCasper Webers, Ivette Essers, Sofia Ramiro, et al.
Rheumatology and Therapy|October 18, 2021
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2Vibeke Strand, Filip Van den Bosch, Roberto Ranza, et al.
The Journal of Rheumatology|May 19, 2009
Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcomeAnnelies Boonen, Bert vander Cruyssen, Kurt de Vlam, et al.
Annals of the Rheumatic Diseases|January 31, 2007
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practiceBert Vander Cruyssen, Clio Ribbens, Annelies Boonen, et al.
Rheumatology (Oxford, England)|December 23, 2025
Work participation and work disability in Belgian patients with systemic sclerosisIne Desimpele, Ann-Sophie De Craemer, Saskia Decuman, et al.
RMD Open|April 4, 2025
Long-term evolution of postpartum sacroiliac bone marrow oedema: a 5-year longitudinal follow-up studyGaëlle Varkas, Liesbet De Meester, Manouk de Hooge, et al.
The Journal of Rheumatology|October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activityBert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
RMD Open|May 3, 2023
Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohortsManouk de Hooge, Alla Ishchenko, Ann-Sophie De Craemer, et al.
Pageof 20